Communication Strategies to Increase HPV Vaccination Intention
Launched by UNIVERSITY OF PENNSYLVANIA · Jan 16, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how different ways of communicating can encourage more adults to get the Human Papillomavirus (HPV) vaccine, which is important for preventing certain types of cancers related to HPV. Despite the vaccine's effectiveness, many adults still hesitate to get vaccinated. The researchers will conduct a survey with over 3,600 adults aged 18 to 45 years to discover which messages about the vaccine are most effective in motivating people to get vaccinated.
If you are between the ages of 18 and 45 and have not received the HPV vaccine (or are unsure if you have), you may be eligible to participate in this study. Participants can expect to answer questions about various communication strategies regarding the HPV vaccine. This research aims to find better ways to inform and encourage people to protect their health through vaccination. Your input could help improve public health efforts in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-45 years old
- Exclusion Criteria:
- • Under 18 and over 45 years old
- • Received HPV vaccine or unsure about receipt
About University Of Pennsylvania
The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported